Home › NCT06829394
Transitional Housing and HIV Health
A Type 1 Hybrid Effectiveness-Implementation Evaluation of a City-Level Transitional Housing Program's Effects on Health, Economic, and Psychologic Outcomes Among People With HIV
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: Inclusion criteria for the Lottery Population will be all PWH in priority groups 1 or 2 included in the initial lottery for access to the AAY program. Inclusion criteria for the Survey population is (1) eligible for the HIV transitional housing program (2) priority group 1 or 2 with anticipated inclusion in the initial lottery (3) no plans to leave Philadelphia in the next year (4) regular access to a telephone to be able to complete phone surveys (5) able to provide informed consent. \- Exclusion Criteria: Does not meet the above inclusion criteria. \-
About the study
The goal of this pilot study is to evaluate the implementation and outcomes of the Arms Around You (AAY) program, a supportive housing initiative launched by the Philadelphia Department of Public Health (PDPH) in 2024. The program aims to address housing instability among people with HIV (PWH) using a Housing First model. The main questions it seeks to answer are:
1. How does AAY affect HIV-related outcomes, particularly viral suppression and antiretroviral therapy (ART) adherence? 2. What are the program's effects on economic, psychological, and secondary health outcomes? 3. How feasible, acceptable, and scalable is the program for broader implementation? Participants will be assigned to immediate program access or a waitlist using a random lottery system, creating treatment and control groups, respectively. Surveys and health data will be collected at baseline and over 36 months to assess changes in outcomes such as viral suppression, housing security, mental health, and financial well-being. Qualitative interviews with participants and stakeholders will complement quantitative findings to explore mechanisms of change and guide program optimization.
What is being tested
- Program Assignment (other)
Sponsor: University of Pennsylvania · Participants: 200 · Started: Feb 25, 2025
Contact the study team
- Aaron Richterman, MD, MPH · Phone: 267-441-7915
- Eva Fabian, MPH · Phone: 760-791-2633
Official record on ClinicalTrials.gov — NCT06829394
Locations in the U.S.
| Pennsylvania | University of Pennsylvania, Philadelphia (Not yet recruiting) University of Pennsylvania, Philadelphia |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.